Studies evaluating the prognostic and clinicopathologic significance of PD-L1 expression in PCa are limited, and the curative effect of anti-PD-1/PD-L1 therapy on PCa remains controversial. The gene discussed is CD274; the disease is posterior cortical atrophy.